While the present results about changes in THBS1 expression in human IVD and its function in cell communication and regulating gene expression in AF and NP cells classify THBS1 as a candidate therapeutic target for IDD, additional in vivo assessment of its role in an animal model of IDD would further support this notion. Here, THBS1 is linked to atrial fibrillation.